News Focus
News Focus
Replies to #17197 on Biotech Values
icon url

DewDiligence

10/20/05 6:26 PM

#17200 RE: rfj1862 #17197

Dr. Leonard Saltz of Sloan Kettering thinks FOLFOX and FOLFIRI are equally meritorious in first-line metastatic colorectal cancer. He does not do any screening to select one or the other. FWIW